Search for: "Eli Lilly " Results 581 - 600 of 2,137
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2011, 3:42 am by sally
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) Smith & Anor v Jafton Properties Ltd [2011] EWCA Civ 1251 (02 November 2011) Shiva Ltd v Transport for London [2011] EWCA Civ 1189 (02 November 2011) High Court (Chancery Division) Business Dream Ltd, Re Insolvency Act 1986 [2011] EWHC 2860 (Ch) (02 November 2011) High… [read post]
2 Feb 2009, 9:07 pm
The new drug in question is called prasugrel and would be marketed by Eli Lilly & Co with potential co-marketing by Japan's Daiichi Sankyo Co., the drug's discoverer.Reports issued suggest that prasugrel may be more effective than Plavix in preventing heart attacks, but also a higher risk to cause dangerous bleeding. [read post]
27 Oct 2011, 11:48 am by Gene Quinn
Exactly who is to blame if a pharmaceutical company, say Eli Lilly, decides to invest billions of dollars and build a facility when they haven't adequately protected their own intellectual property? [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
30 Jan 2009, 6:08 pm
" So, right now, Eli Lilly is right on the cusp of that and they're beginning to settle suits. [read post]
3 Mar 2016, 6:37 am by Michael Geist
It recently waded into the case that most clearly crystallizes the dangers of trade and IP in Canada: the Eli Lilly claim for compensation from Canadian taxpayers for hundreds of millions of dollars due to a pair of patent law decisions. [read post]
5 Oct 2022, 6:51 am by Dennis Crouch
” In re Eli Lilly and Co., 37 F.4th 160 (4th Cir. 2022). [read post]
14 Dec 2023, 12:15 pm by Chad Landmon
Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. [read post]
4 Sep 2016, 8:48 pm by Patent Docs
Presentations will be made by Duane Marks of Eli Lilly and Company and Damian Porcari of Ford Motor Company. [read post]
25 May 2014, 8:05 pm by Patent Docs
A panel consisting of Robert Armitage, Eli Lilly and Co. [read post]
14 Dec 2023, 12:15 pm by Chad Landmon
Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. [read post]
9 Dec 2017, 9:14 pm by Patent Docs
Jane Love of Gibson, Dunn & Crutcher LLP, Duane Marks of Eli Lilly & Company, and Irena Royzman of Patterson Belknap Webb & Tyler LLP will discuss: • What is now needed by way of written description to create a valid patent on an antibody? [read post]
30 Dec 2012, 9:30 pm by Patent Docs
Eli Lilly and Company v. [read post]
16 May 2014, 9:45 pm by Patent Docs
The conference will provide optimal strategies to help attendees maximize their patent portfolios, including: • The radical SPC decisions in Georgetown University, Actavis and Eli Lilly; • Capitalise on second medical use patents by implementing proven strategies and utilising tactical enforcement and remedial methods; • Fundamental update on the imminent Unitary Patent and Unified Patent Court and how to adapt business strategies effectively; • The… [read post]